A second chance for promising but unprofitable drugs

One of the unfortunate realities of the pharmaceuticals industry is that promising new drugs are sometimes abandoned simply because they’re not likely to be profitable. Aiming to give such medicines a chance at a new life — not to mention the patients who might benefit from them — Cinderella Therapeutics is a Dutch not-for-profit enterprise that picks up the most promising of such therapies and continues testing them.